Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on Most Favored Nation
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies:"For too many years, Americans have subsidized the research…
Learn more
BIO Statement on Industry Tariffs
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented medicines in the US:“We share the Administration’s…
Learn more
BIO Extends Agreement with Avantor for Five…
Collaboration maximizes BIO members’ access to Avantor’s market-leading portfolio of products, materials, and services to accelerate scientific innovation. WASHINGTON, D.C., September 17, 2025 - The Biotechnology Innovation Organization (BIO)…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
Siddhartha Mukherjee, author of “The Emperor of All Maladies: A Biography of Cancer” to Open on Keynote Stage at BIO 2019
March 28, 2019
Pulitzer Prize-winning author, physician and oncologist, Siddhartha Mukherjee with headline BIO 2019 in a keynote speach on Tuesday, June 4.  He is the author of The Emperor of All Maladies: A Biography of Cancer, and the New York…
BIO Applauds Bipartisan Senate Letter on U.S.-China Trade Negotiations
March 14, 2019
BIO President and CEO Jim Greenwood today applauded a letter authored by Senators Pat Roberts (R-Kan.) and Debbie Stabenow (D-Mich.) to President Trump urging him to continue prioritizing in U.S.-China trade negotiations the need for China to…
BIO Urges Congress to Extend Biofuels Tax Incentives
March 12, 2019
The Biotechnology Innovation Organization BIO today submitted the following statement for the record to the House Ways and Means Subcommittee on Select Revenue Measures urging Congress to retroactively extend the biofuels tax incentives that…
BIO Applauds Trump Administration for Moving Closer to Fulfilling E15 Promise
March 12, 2019
The Biotechnology Innovation Organization (BIO) released the following statement after the U.S. Environmental Protection Agency (EPA) announced its proposed rule allowing for the summertime use of E15 gasoline.
BIO Statement on President’s Proposed 2020 Budget
March 11, 2019
Washington, DC (March 11, 2019) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding President Trump’s FY 2020 budget proposal:
BIO Applauds FDA Action on AquAdvantage® Salmon
March 8, 2019
The Biotechnology Innovation Organization (BIO) released the following statement on the action taken today by the U.S. Food & Drug Administration (FDA) which will allow AquaBounty Technologies, an American company, to commercialize its…
BIO Applauds Multi-Agency Framework for Advancing the Bioeconomy
March 5, 2019
The Biotechnology Innovation Organization (BIO) today released the following statement in response to the release of The Bioeconomy Initiative: Implementation Framework, a multi-agency strategy aimed at accelerating innovative technologies that…
BIO Statement on Ambassador Lighthizer and Secretary Perdue Testimonies
February 27, 2019
BIO President and CEO Jim Greenwood released the following statement on U.S. Trade Representative Robert Lighthizer’s testimony at a House Ways and Means Committee hearing on the U.S.-China trade deal and U.S. Secretary of Agriculture Sonny…
BIO Announces Partnership with Taiwan BIO for 2019 Conference and Exhibition
February 20, 2019
Washington, DC (February 20, 2019) – The Biotechnology Innovation Organization (BIO) announced today it will join the Taiwan Bio-Industry Organization (Taiwan BIO) to host BIO Asia-Taiwan from July 24-28 in Taipei, Taiwan. The event…
BIO Statement on CMS Proposed Decision Memo for the CAR-T National Coverage Determination
February 15, 2019
BIO Executive Vice President for Health Policy Dan Durham issued the following statement regarding the CMS proposed decision memo for the CAR-T National Coverage Determination.
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today